Eticovo Dosage
Generic name: etanercept 25mg in 0.5mL
Dosage form: injection, solution
Drug classes: Antirheumatics, TNF alfa inhibitors
Medically reviewed by Drugs.com. Last updated on Apr 29, 2024.
Adult Patients
Eticovo is administered by subcutaneous injection.
Patient Population | Recommended Dosage Strength and Frequency |
Adult RA, AS, and PsA | 50 mg weekly |
Adult PsO | Starting Dose: 50 mg twice weekly for 3 months Maintenance Dose: 50 mg once weekly |
See the Eticovo (etanercept-ykro) “Instructions for Use” insert for detailed information on injection site selection and dose administration.
Adult Rheumatoid Arthritis, Ankylosing Spondylitis, and Psoriatic Arthritis Patients
Methotrexate, glucocorticoids, salicylates, nonsteroidal anti-inflammatory drugs (NSAIDs), or analgesics may be continued during treatment with Eticovo.
Based on a study of 50 mg etanercept twice weekly in patients with RA that suggested higher incidence of adverse reactions but similar American College of Rheumatology (ACR) response rates, doses higher than 50 mg per week are not recommended.
Pediatric Patients
Eticovo is administered by subcutaneous injection.
Pediatric Patients Weight | Recommended Dose |
63 kg (138 pounds) or more | 50 mg weekly |
Note: There is no dosage form for Eticovo that allows weight base dosing for pediatric patients below 63 kg (138 pounds). To achieve pediatric doses other than 50 mg, use other reconstituted etanercept products lyophilized powder.
Doses of etanercept products higher than those described in Table 2 have not been studied in pediatric patients.
In JIA patients, glucocorticoids, NSAIDs, or analgesics may be continued during treatment with Eticovo.
Preparation of Eticovo
Eticovo is intended for use under the guidance and supervision of a physician. Patients may self-inject when deemed appropriate and if they receive medical follow-up, as necessary. Patients should not self-administer until they receive proper training in how to prepare and administer the correct dose. Administer injections subcutaneously in the thigh, abdomen or outer area of the upper arm.
The Eticovo (etanercept-ykro) “Instructions for Use” insert for each presentation contains more detailed instructions on injection site selection and the preparation of Eticovo.
Preparation of Eticovo Single-dose Prefilled Syringe
For a more comfortable injection, leave Eticovo single-dose prefilled syringe at room temperature for at least 30 minutes before injecting. DO NOT remove the needle cover while allowing the prefilled syringe to reach room temperature.
Inspect visually for particulate matter and discoloration prior to administration. There may be small white particles of protein in the solution. This is not unusual for proteinaceous solutions. The solution should not be used if discolored or cloudy, or if foreign particulate matter is present.
Frequently asked questions
- What are the new drugs for rheumatoid arthritis (RA)?
- What are biosimilar drugs and how do they compare to biologics?
- What are the new drugs for plaque psoriasis?
- What biosimilars have been approved in the United States?
- Does perispinal etanercept work for stroke recovery?
- How long does it take for Enbrel (etanercept) to work?
- How long can Enbrel (etanercept) be left unrefrigerated?
- Can Enbrel (etanercept) be taken with antibiotics?
More about Eticovo (etanercept)
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- FDA approval history
- Drug class: antirheumatics
- Breastfeeding
Patient resources
- Eticovo (Etanercept Subcutaneous) advanced reading
- Eticovo (Etanercept-ykro Subcutaneous) (Advanced Reading)
Other brands
Professional resources
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.